CAROLE PINDARO: Open Payments
NPI 1619988136 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 47 payments from 4 companies in 2025. Trend: 2023 $623 · 2024 $1,213 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 24 | $425 |
| Gilead Sciences, Inc. | 18 | $418 |
| Merck Sharp & Dohme LLC | 4 | $66 |
| Amgen Inc. | 1 | $17 |
Products named: DOVATO, Biktarvy, CABENUVA, PIFELTRO, APRETUDE, REPATHA, RUKOBIA.
Industry payments across LA — which companies pay providers there.
